Sansure Biotech Inc.
SSE:688289.SS
19.92 (CNY) • At close June 11, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 4,590.157 | 4,233.488 | 3,212.589 | 2,636.223 | 2,590.8 | 99.166 | 127.012 | 39.909 |
| Short Term Investments
| 139.671 | 548.279 | 2,451.199 | 2,046.455 | 1,601.225 | 66.329 | 0 | 0 |
| Cash and Short Term Investments
| 4,729.828 | 4,781.767 | 5,663.788 | 4,682.677 | 4,192.025 | 165.494 | 127.012 | 39.909 |
| Net Receivables
| 588.273 | 692.257 | 1,298.09 | 807.658 | 546.395 | 188.298 | 161.16 | 114.557 |
| Inventory
| 392.754 | 376.633 | 355.313 | 369.503 | 276.736 | 64.663 | 55.898 | 40.871 |
| Other Current Assets
| 78.705 | 98.937 | 208.245 | 106.382 | 67.548 | 18.748 | 15.041 | 123.09 |
| Total Current Assets
| 5,789.56 | 5,949.594 | 7,525.436 | 5,966.221 | 5,082.704 | 437.204 | 359.111 | 318.427 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 1,112.662 | 1,055.224 | 785.267 | 481.03 | 216.544 | 176.508 | 162.695 | 161.064 |
| Goodwill
| 7.662 | 7.662 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 429.364 | 327.966 | 84.441 | 45.554 | 31.234 | 11.492 | 11.238 | 10.674 |
| Goodwill and Intangible Assets
| 437.027 | 335.628 | 84.441 | 45.554 | 31.234 | 11.492 | 11.238 | 10.674 |
| Long Term Investments
| 955.986 | 974.33 | -1,793.767 | -1,533.229 | -1,498.718 | 4.768 | 3.418 | 4.029 |
| Tax Assets
| 69.276 | 73.823 | 69.619 | 24.996 | 17.225 | 11.468 | 11.932 | 15.817 |
| Other Non-Current Assets
| 239.286 | 65.606 | 2,502.765 | 2,105.799 | 1,605.384 | 1.026 | 3.648 | 55.6 |
| Total Non-Current Assets
| 2,814.236 | 2,504.611 | 1,648.326 | 1,124.149 | 371.67 | 205.261 | 192.931 | 247.185 |
| Total Assets
| 8,603.796 | 8,454.205 | 9,173.762 | 7,090.37 | 5,454.374 | 642.465 | 552.043 | 565.612 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 395.443 | 468.65 | 791.414 | 258.7 | 272.268 | 35.263 | 42.553 | 21.611 |
| Short Term Debt
| 9 | 9 | 14.259 | 8.49 | 55 | 0 | 0 | 0 |
| Tax Payables
| 9.6 | 17.66 | 216.358 | 101.311 | 112.065 | 4.658 | 3.961 | 1.945 |
| Deferred Revenue
| 0 | 0 | 53.109 | 394.352 | 358.092 | 6.614 | 5.314 | 6.49 |
| Other Current Liabilities
| 340.761 | 423.843 | 549.695 | 216.793 | 186.884 | 33.442 | 98.665 | 97.368 |
| Total Current Liabilities
| 754.803 | 919.153 | 1,571.726 | 663.934 | 688.689 | 73.363 | 145.18 | 120.924 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 408.571 | 18.211 | 13.597 | 6.407 | 3.18 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 39.883 | 0 | 30.531 | 25.678 | 18.95 | 11.427 | 10.576 | 10.1 |
| Deferred Tax Liabilities Non-Current
| 54.753 | 59.447 | 19.045 | 13.01 | 1.31 | 0.199 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 32.487 | 26.091 | 0 | -3.18 | 0 | 0 | 55.6 |
| Total Non-Current Liabilities
| 503.207 | 110.145 | 89.264 | 45.095 | 20.26 | 11.626 | 10.576 | 65.7 |
| Total Liabilities
| 1,258.011 | 1,029.298 | 1,660.989 | 709.029 | 708.949 | 84.989 | 155.755 | 186.624 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 582.388 | 588.46 | 588.46 | 400 | 400 | 360 | 127.862 | 127.862 |
| Retained Earnings
| 4,900.14 | 4,882.679 | 5,077.081 | 3,820.02 | 2,026.634 | -28.234 | -300.386 | -307.148 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 377.423 | 293.951 | 263.845 | 0.034 | 568.811 | 558.274 |
| Other Total Stockholders Equity
| 1,760.698 | 1,730.133 | 1,457.653 | 1,854.936 | 2,054.946 | 225.676 | 568.794 | 558.274 |
| Total Shareholders Equity
| 7,243.226 | 7,201.271 | 7,500.617 | 6,368.907 | 4,745.425 | 557.476 | 396.287 | 378.988 |
| Total Equity
| 7,345.786 | 7,424.907 | 7,512.773 | 6,381.341 | 4,745.425 | 557.476 | 396.287 | 378.988 |
| Total Liabilities & Shareholders Equity
| 8,603.796 | 8,454.205 | 9,173.762 | 7,090.37 | 5,454.374 | 642.465 | 552.043 | 565.612 |